Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Tenet Healthcare Corp.'s profit dropped in the fourth quarter after revenue and grant income related to the Covid-19 pandemic declined.

Dow Jones Newswires: Tenet Healthcare Q4 profit slides

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2021 (Q4'21). Tenet's results for Q4'21 versus the quarter ended December 31, 2020 (Q4'20) and for the year ended December 31, 2021 (FY 2021) versus the year ended December 31, 2020 (FY 2020) follow: ($ in millions, except per share results) Q4'21 Q4'20 FY 2021 FY 2020 Net income available to Tenet common shareholders from continuing operations $250 $414 $915

Tenet Reports Strong Fourth Quarter and FY 2021 Results; Announces Plan to Retire $700 Million of Debt; Provides Detailed 2022 Financial Outlook

Amgen

Simon Property Group

While not quite the shock that Meta Platforms sprung on Wednesday, two companies that reported after markets closed Thursday have reversed the sentiment that prevailed.

Earnings Previews: Amgen, Simon Property, Tenet Healthcare

DALLAS, Jan. 25, 2022 /PRNewswire/ -- GI Alliance, the nation's largest independent gastroenterology services organization, is pleased to announce the formation of a new joint venture with United Surgical Partners International (USPI). USPI's partnership with GI Alliance offers patients best-in-class gastroenterology care through a collaborative approach.

GI Alliance and USPI Form Partnership to Expand GI Presence in Texas

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its fourth quarter ended December 31, 2021 after the market closes on Monday, February 7, 2022. The company will host a related conference call the following morning, Tuesday, February 8, 2022, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About

Tenet to Report its Fourth Quarter 2021 Results on February 7

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present virtually at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, beginning at 3:00 p.m. Eastern time (2:00 p.m. Central time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a d

Tenet to Participate in J.P. Morgan Healthcare Conference

Universal Health Services

Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow in the promising hospital space. On comparative evaluation, we try to find out which one scores over the other.

UHS or THC: Which Stock is Better-Placed at the Moment?

Banking on a solid guidance, enhanced portfolio and strategic measures, Tenet Healthcare (THC) holds enough potential to reap benefits for investors.

Tenet Healthcare (THC) Soars 95.8% YTD: More Room to Run?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) and its subsidiary United Surgical Partners International (USPI) today completed their previously announced transaction to acquire SurgCenter Development (SCD). In connection with the closing of the transaction, Tenet/USPI acquired SCD's ownership interests in 86 ambulatory surgery centers (ASCs) and other related ambulatory support services for approximately $1.1 billion. Additionally, USPI is offering to acquire a portion of eq

Tenet and USPI Complete Transaction to Acquire SCD

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities Leveraged Finance Conference on Tuesday, November 30, 2021, beginning at 9:45 a.m. Eastern time (8:45 a.m. Central time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a

Tenet to Participate in BofA Securities Leveraged Finance Conference

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Tenet (THC) Up 11.7% Since Last Earnings Report: Can It Continue?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) announced today that Regina Nethery, Vice President of Investor Relations, has chosen to retire from her position, effective at the end of 2021. “We are extremely grateful to Regina for her thoughtful, strategic counsel and tremendous contributions to the organization throughout her tenure,” said Dan Cancelmi, Executive Vice President and Chief Financial Officer. “Regina's recent recognition as one of the best Investor Relations

Regina Nethery to Retire as Vice President of Investor Relations

Tenet Healthcare (THC) issues senior notes to procure funds. The move further highlights THC's sound financial position.

Tenet Healthcare (THC) Offers Senior Secured Notes of $1.45B

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.450 billion in aggregate principal amount of senior secured first lien notes due on January 15, 2030, which will bear interest at a rate of 4.375% per annum (the “notes”). Completion of the notes offering is expected to occur on December 1, 2021, and is subject to, among other things, standard closing and market

Tenet Announces Pricing of its $1.450 Billion Private Offering of Senior Secured Notes

Hospital operator Tenet Healthcare Corp. THC, +1.39% said Tuesday it is planning a private placement of $1.45 billion of nine-year, high-yield bonds. Process will be used to fund the acquisition of Surgical Center Development #3, LLC and Surgical Center Development #4, LLC's ownership interest in a portfolio of 92 ambulatory surgery centers and certain other related assets, the company said.

Tenet Healthcare offering $1.45 billion of nine-year high-yield bonds

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.450 billion in aggregate principal amount of newly issued senior secured first lien notes maturing in 2030 (the “notes”). Completion of the offering is subject to, among other things, pricing and standard closing and market conditions. Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance the acquisition of Surgical Cente

Tenet Announces $1.450 Billion Private Offering of Senior Secured Notes

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Wolfe Research Virtual Healthcare Conference on Thursday, November 18, 2021, beginning at 11:00 a.m. Eastern time (10:00 a.m. Central time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) i

Tenet to Participate in Wolfe Research Virtual Healthcare Conference

Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.

Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC), and its subsidiary United Surgical Partners International (USPI), today announced that they have entered into a definitive agreement with the principals of SurgCenter Development (SCD) to acquire SCD. Under the terms of the agreement, Tenet/USPI will acquire SCD's ownership interests in 92 ambulatory surgery centers (ASCs) and other related ambulatory support services (collectively, the Portfolio). USPI and SCD's principals will

Tenet and USPI to Acquire SurgCenter Development and Establish Long-Term Development Partnership

Acadia Healthcare

HCA Healthcare

Expanding patient volumes, use of telehealth services, cost-control measures and an aging demography are tailwinds to the hospital industry players like HCA, UHS, THC and ACHC.

4 Hospital Stocks to Gain From Rebounding Patient Volumes

The consensus price target hints at a 25.3% upside potential for Tenet (THC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Can Tenet (THC) Climb 25% to Reach the Level Wall Street Analysts Expect?

ACADIA Pharma

Anthem

MEDNAX

Teladoc

UnitedHealth Group

Vertex Pharmaceuticals

Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.

4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes

Tenet Healthcare (THC) has been struggling lately, but the selling pressure may be coming to an end soon.

Tenet Healthcare (THC) Sees Hammer Chart Pattern: Time to Buy?

Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.

Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y

Tenet Healthcare Corporation (THC) CEO Saum Sutaria on Q3 2021 Results - Earnings Call Transcript

News for Tenet Healthcare Stock (THC)